SUBSCRIBE
SUBSCRIBE

Biogen

NEWS
How Biogen Makes Most of Its Cash
Business
Biogen’s CEO Hunt Holds Company in Limbo
October 27, 2016
 · 
3 min read
Investors Sigh With Relief as Biogen's Alzheimer's Drug Delivers in Early-Stage Study
Drug Development
Why Biogen’s Fate May Depend on Eli Lilly’s Alzheimer’s Data
October 27, 2016
 · 
3 min read
Investors Sigh With Relief as Biogen's Alzheimer's Drug Delivers in Early-Stage Study
Genetown
Biogen Quietly Kills Autoimmune Program
October 26, 2016
 · 
3 min read
Business
Biogen Could Add $1 Billion In 2017 On Muscular Dystrophy Drug
October 25, 2016
 · 
1 min read
Business
What to Look Out for When Biogen, Vertex Report Q3 This Week
October 24, 2016
 · 
1 min read
Biotech Bay
Celgene Pitted Against Gilead, Biogen In Crohn’s Drug Battle
October 19, 2016
 · 
1 min read
Investors Sigh With Relief as Biogen's Alzheimer's Drug Delivers in Early-Stage Study
Policy
The History Between a Biogen Drug and a High-Profile Democratic Party Fundraiser
October 17, 2016
 · 
2 min read
Genetown
Biogen Investors: Save The Date For October 26
October 14, 2016
 · 
1 min read
Massachusetts' Biostage Slashes 71% of Staff, Evaluating Strategic Alternatives
Deals
Why Incyte, Biogen and BioMarin are Hot Acquisition Targets
October 12, 2016
 · 
3 min read
Load More
AWARDS
  • 2022 Best Places to Work
  • 2023 Best Places to Work
JOBS
IN THE PRESS
Deals
Biogen Idec, Inc. (Massachusetts) Sells BENLYSTA Royalty Rights to DRI Capital Managed Fund
September 10, 2012
 · 
1 min read
Genetown
Biogen Idec, Inc. (Massachusetts) to Present at the Morgan Stanley Global Healthcare Unplugged Conference
September 5, 2012
 · 
1 min read
Genetown
Biogen Idec, Inc. (Massachusetts) to Present at the Stifel Nicolaus Healthcare Conference 2012
August 30, 2012
 · 
1 min read
Business
Biogen Idec Foundation Donates $100,000 to Launch STEM Education Collaboration With Teach for America
August 17, 2012
 · 
1 min read
Business
Biogen Idec, Inc. (Massachusetts), Regulus Therapeutics, Inc. Cut Deal to Monitor MS
August 16, 2012
 · 
7 min read
Deals
Alzheimer’s Setback Makes Elan Corporation PLC Takeover Bait to Biogen Idec, Inc. (Massachusetts)
July 27, 2012
 · 
1 min read
Business
Biogen Idec, Inc. (Massachusetts) Increases Revenue 18% to $1.4 Billion in the Second Quarter
July 24, 2012
 · 
1 min read
Drug Development
Biogen Idec, Inc. (Massachusetts), Bayer AG Drugs Fail to Slow MS Progression
July 18, 2012
 · 
1 min read
Business
Biogen Idec, Inc. (Massachusetts) Announces Collaboration With Leading Research Institutions to Sequence Genomes of Patients With ALS
July 17, 2012
 · 
1 min read
Business
Biogen Idec, Inc. (Massachusetts) to Report Second Quarter 2012 Financial Results on July 24, 2012
July 6, 2012
 · 
1 min read
Load More